Abstract Genome-wide mutagenesis was performed in mice to identify candidate genes for male infertility, for which the predominant causes remain idiopathic. Mice were mutagenized using N-ethyl-N-nitrosourea (ENU), bred, and screened for phenotypes associated with the male urogenital system. Fifteen heritable lines were isolated and chromosomal loci were assigned using low-density genome-wide SNP arrays. Ten of the 15 lines were pursued further using higher-resolution SNP analysis to narrow the candidate gene regions. Exon sequencing of candidate genes identified mutations in mice with cystic kidneys (Bicc1), cryptorchidism (Rxfp2), restricted germ cell deficiency (Plk4), and severe germ cell deficiency (Prdm9). In two other lines with severe hypogonadism, candidate sequencing failed to identify mutations, suggesting defects in genes with previously undocumented roles in gonadal function. These genomic intervals were sequenced in their entirety and a candidate mutation was identified in SnrpE in one of the two lines. The line harboring the SnrpE variant retains substantial spermatogenesis despite small testis size, an unusual phenotype. In addition to the reproductive defects, heritable phenotypes were observed in mice with ataxia (Myo5a), tremors (Pmp22), growth retardation (unknown gene), and hydrocephalus (unknown gene). These results demonstrate that the ENU screen is an effective tool for identifying potential causes of male infertility.
Introduction
Male infertility affects approximately 10-15% of men (Irvine 1998) . The causes are heterogeneous and include testicular dysgenesis, defects in spermatogenesis, obstructive disorders, gonadotropin deficiency, and abnormalities of testosterone synthesis or action, among other causes (Brugh and Lipshultz 2004) . Although most cases of male infertility remain idiopathic, an increasing number of genetic causes are being recognized (O'Flynn O'Brien et al. 2010) . Initially, chromosomal disorders such as 47/XYY, Klinefelter's syndrome (Foresta et al. 2002) , and translocations or deletions of the Y chromosome were described (Kuroda-Kawaguchi et al. 2001 ). More recently, specific genes involved in testis development (e.g., SRY, DAX1, SF1), descent (INSL3, RFXP2), or spermatogenesis (AZFa, AZFb, AZFc loci; CDY, TSPY) have also been identified (O'Flynn O'Brien et al. 2010; Tyler-Smith et al. 2009) .
A large array of other genes and chromosomal loci has been associated with spermatogenesis or male fertility. There are currently over 400 mouse models with reproductive defects (Matzuk et al. 2008) , and about 150 of these exhibit male infertility (O'Bryan and de Kretser 2006) . A search of the Online Mendelian Inheritance in Man (OMIM) database yields 141 results linked to male infertility, comparable to that for mice. Nonetheless, it is difficult to know with certainty how many of these genes are causative. In addition, deep sequencing of normal human tissues identified 857 genes whose expression is largely restricted to the testis (Jongeneel et al. 2005) . Thus, the number of candidates to test remains very large and the number of genes identified as a cause of male infertility remains small.
In the last decade candidate gene testing has been supplemented by genome-wide methods for identifying disease genes (Clark et al. 2004 ). In one approach, the mouse genome is mutagenized in an unbiased manner using N-ethyl-N-nitrosourea (ENU), a chemical that increases the natural mutation rate by a factor of 130-160 (Guenet 2004 ). The resulting animals are then bred and screened for heritable phenotypes of interest, a process referred to as forward genetics. Typically, the result of ENU mutagenesis is a nucleotide substitution (Justice et al. 1999 ). An advantage of this method over targeted mutagenesis is the ability of point mutations to create hypomorphic alleles, in which single amino acid substitutions result in less severe or more restricted phenotypes than gene deletion (Debruyne et al. 2006) . Hypomorphs are useful for studying genes that are required for embryonic development, where a complete knockout would be lethal, or in cases where a primary phenotype masks a secondary trait of specific interest (Acevedo-Arozena et al. 2008) .
Worldwide, at least three centers are performing genome-wide screens specifically for reproductive mutants (Kennedy and O'Bryan 2006) . One of these, the Reproductive Genomics Group at the Jackson Laboratory, used a three-generation breeding scheme to identify recessive mutations that cause infertility (Furnes and Schimenti 2007) . This group screened 413 G1 males, mapping 32 lines with male infertility, 3 lines with female infertility, and 7 lines in which both sexes were infertile. This group has reported at least six mutant genes from this series (Bannister et al. 2007; Ching et al. 2010a, b; Harris et al. 2007; Philipps et al. 2008; Ward et al. 2007) .
In this article we report an ENU-based screen focused on genes that cause germ cell deficiency and hypogonadism. Using both dominant and recessive breeding schemes, we screened 1,014 G1 males and mapped 15 reproductive mutants to chromosomal loci. Mutations were identified in six lines through candidate sequencing. In two additional cases where candidate sequencing was uninformative, genomic resequencing identified one novel gene as a candidate for hypogonadism. The remaining mutation remains unidentified.
Materials and methods

ENU mutagenesis and breeding
Male mice of the C57BL/6 J (B6) strain were mutagenized in the Northwestern University Center for Functional Genomics as described previously (Vitaterna et al. 1994 (Vitaterna et al. , 2006 . ENUtreated males (G0 generation) were allowed 12 weeks to recover fertility and were then crossed to untreated B6 females, yielding G1 generation males and females. For the cross designed to detect dominant mutants, G1 males and females were bred to wild-type DBA mice and the resulting F1 male progeny were screened. For the cross designed to detect recessive mutants, G1 males were bred to wild-type B6 females and the resulting G2 females were back-crossed to their G1 fathers, yielding G3 male progeny for screening. All mice to be screened were monitored for obvious defects until after puberty and killed between 6 and 8 weeks of age. The kidneys, seminal vesicles, epididymides, and testes were examined in situ for size and location. The testes and epididymides were then dissected and the testes were weighed. Developmental defects (e.g., cystic kidneys or cryptorchidism) and severe hypogonadism were detected at this point in the screen.
Histology
The testes were fixed in Bouin's fixative and the epididymides were fixed in 10% neutral buffered formalin. After fixation, one testis was cut in half longitudinally and the other testis was cut in cross section. The four testis halves and the two epididymides were embedded in a single paraffin block such that one 5-lM section captured all six pieces of tissue. Sections were stained with hematoxylin and eosin and examined for histological defects, including spermatogenic block, loss of germ cell layers or Sertoli cell-only tubules in the testes, or an absence of sperm or the presence of round germ cells in the epididymides.
Genetic mapping of putative mutants
For lines that exhibited heritable phenotypes of interest, affected animals on the B6 background were back-crossed to wild-type DBA mice to create an F1 generation. For dominant mutants, F1 mice were again crossed to wild-type DBA mice to create the N2 generation, which underwent the necessary meiotic recombination for mapping. For recessive mutants, F1 mice were intercrossed to create the F2 generation for mapping. Mice from the F2 and N2 generations were mapped using genome-wide 384-and 768-SNP arrays (Moran et al. 2006) , yielding chromosomal assignments and loci of between 9 and 77 Mb. In six lines (624, 1003, 840, 924, 1, and 1105) where the phenotype had low penetrance or there was an absence of obvious candidate genes, the genes were not pursued further. Mutated genes in five other lines (1163, 1247, 1006, 1061, and 708) were identified by sequencing exons of candidates in these regions (Myo5a, Pmp22, Bicc1, Rxfp2, and Plk4). For the remaining four mutants (1046, 1045, 1078, and 1157) , high-density mapping was performed using a custom 384-SNP array designed using the Illumina Golden Gate platform, including the manufacturer's design software, protocols, and reagents (Illumina, Inc., San Diego, CA). This array was targeted to the four regions identified in the lowdensity screen. SNPs were placed on average every 0.5 Mb. Between 28 and 246 samples were mapped for each of these lines, and sequencing of candidate genes in the narrowed regions identified one additional mutation (Prdm9).
Resequencing of genomic intervals
For lines 1078 and 1157, SNP-mapped intervals were enriched using genomic DNA from affected animals and B6 and DBA controls. Capture arrays were designed using the Agilent eArray software and libraries were prepared using Agilent SureSelect reagents (Agilent Technologies, Palo Alto, CA). Sequencing was performed on the Applied Biosystems SOLiD platform, and putative sequence variants were identified using the Applied Biosystems BioScope software (Applied Biosystems, Life Technologies, Carlsbad, CA). All work was performed by the Northwestern University Genomics Core Facility using the manufacturer's protocols and reagents. Additional analysis was also undertaken at the Institute for Computational Biomedicine at Weill Cornell Medical College. The variants were confirmed using a pipeline that utilized the Burrows-Wheller Aligner (BWA) and SAMtools for variant calling.
Validation of identified mutations
All sequence variants were compared to public databases to identify known SNPs. For variants that were not present in available databases, background strains (B6, DBA) were sequenced to identify previously unreported SNPs. SNPs were not pursued further. The remaining variants were sequenced in complete litters from the relevant line to confirm that the variant segregated with the phenotype in affected and unaffected littermates. Variants that segregated appropriately were then sequenced in larger numbers of affected and unaffected animals from the colony to establish the frequency of transmission.
Results
Mutagenesis and genetic mapping
Male mice of the C57BL/6 J strain (B6) were treated with ENU, allowed to recover their fertility over 12 weeks, and then mated with untreated B6 females to create the G1 generation (Vitaterna et al. 1994) . The germline in ENUtreated mice is chimeric, but each G1 mouse inherits a novel set of mutations, of which generally no more than one causes a phenotype of interest. To identify dominant reproductive mutants, F1 offspring from 1,014 G1 males and females mated to untreated mice were examined (Fig. 1a) . To identify recessive mutations, or to identify recessive traits in weakly penetrant dominant crosses, G3 offspring from 75 G1 males mated to their G2 offspring were examined. In some cases where only a small number of F1 or G3 offspring were born, mice from a subsequent generation were also screened. Males were euthanized between 6 and 8 weeks of age and the urogenital system (testes, epididymides, seminal vesicles, kidneys, bladder, ureters) was examined for morphological defects. The testes and epididymides were then dissected, weighed, fixed, and embedded for histological analysis ( Fig. 1b-d) .
Approximately ten offspring of each line were examined, and a total of 11,124 slides were scored over the course of the screen. Most animals were assessed based on a single histological section, but a subset was examined in more detail. Lines with three or more abnormal animals were assigned a ''putative mutant'' status and analyzed further. The dominant breeding scheme yielded ten mutants, of which five were confirmed to transmit in a dominant manner. One additional mutant was incompletely dominant, exhibiting a milder phenotype in the heterozygous state and a more severe phenotype in the homozygous state, and one mutant was X-linked. The remaining three low-penetrance mutants in the dominant breeding scheme were subsequently found to exhibit more consistent phenotypes in recessive crosses. The recessive breeding scheme yielded four additional recessive mutants and one dominant mutant.
The 15 lines exhibiting heritable phenotypes were backcrossed to mice of the DBA strain. Using genomewide custom SNP arrays, all lines were tentatively mapped to large chromosomal segments (Table 1) . Four lines with germ cell deficiency and one line with abnormal development of the ureters exhibited decreased penetrance after crosses to other strains, precluding more detailed analyses. Four lines exhibited incidental phenotypes (growth retardation, hydrocephalus, ataxia, and tremors). In two of these lines, mutations were identified by sequencing exons from candidate genes (ataxia, Myo5a; tremors, Pmp22). Mutations were identified in two lines with urogenital defects in a similar manner: a line exhibiting cystic kidneys had a mutation in Bicc1, and a line with bilateral cryptorchidism had a mutation in Rxfp2 (Harris et al. 2010) .
The remaining four lines had varying degrees of germ cell deficiency and hypogonadism. Line 708 exhibited dominant inheritance of germ cell deficiency and a mutation was found in Polo-like kinase 4 (Plk4). The phenotype for this line is described elsewhere (Harris et al. 2011) . The remaining three hypogonadal lines are described here and illustrate the spectrum of disorders observed.
Line 1078: Severe hypogonadism and germ cell loss Line 1078 exhibited a mild phenotype in the dominant histological screen; scattered germ cell deficiency was observed in 4 of 21 F1 progeny. F1 mice were then intercrossed to identify potential recessive traits. In the F2 generation, severe hypogonadism was observed in 24% of male progeny (n = 8 of 34) when considering only litters that contained at least one affected animal (i.e., both parents were obligate heterozygotes) (Fig. 2a , also compare Fig. 2b, e) , which is the expected Mendelian ratio for a recessive mutant. Histological analysis of affected mice revealed that every tubule exhibited substantial germ cell deficiency (Fig. 2f) . The most extensively affected tubules contain only Sertoli cells (Fig. 2g, white arrow) . In the other tubules, only premeiotic cells were observed, and many tubules contained cells with condensed, pyknotic nuclei (Fig. 2g, black arrow) .
In an attempt to identify the causative gene, 63 DNA samples from affected animals were fine mapped using additional SNPs, yielding a 1.44-MB region on chromosome 2 (NCBI m37, Chr 2:27917393-29356174). The entire exome from this region was sequenced at the Broad Institute (Cambridge, MA), but no mutations were identified. The entire genomic interval was then resequenced at the Northwestern University Genomics Core Facility, also without identifying a mutation. Line 1157 was identified in the dominant screen based on marked reduction in testis weight. Affected mice (n = 8) in the F1 generation had an average testis weight of 18 mg compared to 108 mg for unaffected littermates (n = 9) (Fig. 3a, also compare b-e) . Unexpectedly, histological examination of hypogonadal testes revealed ongoing spermatogenesis despite the small testis size. Compared to an unaffected littermate (Fig. 3c, d ), most tubules in the hypogonadal testes exhibited normal histology or minimal germ cell deficiency (Fig. 3f, g ), though occasional tubules had more extensive absence of round and elongating spermatids (Fig. 3h) . However, some elongated spermatids were present even in the most severely affected tubules (Fig. 3i) , and multiple stages of spermatogenesis were observed in each testis section, indicating a reduction rather than a failure In an attempt to identify the gene responsible for this novel phenotype, 253 DNA samples from affected animals were mapped, yielding a 1.34-Mb interval on chromosome 1 (NCBI m37, Chr1:134297351-135638666). Exons and intron-exon boundaries were sequenced for 13 candidate genes in this region (Cntn2, Ripk5, Etnk2, Golt1a, Kiss1, Lax1, Lemd1, Lrrn2, Ppp1r15b, Rbbp5, Ren1, Tmem81, and Zc3h11a) but no mutation was identified. The entire genomic interval was then resequenced, which yielded a nonsynonymous mutation (nucleotide T227A; amino acid E51D) in the gene for small nuclear riboprotein E (SnrpE). SnrpE is a highly conserved binding protein for the U family of small nuclear RNAs (Fautsch et al. 1992; Stanford et al. 1988 ).
Line 1045: Incomplete dominance and hypogonadism Line 1045 was identified in the dominant histological screen based on the absence of sperm in the epididymides of F1 mice, despite only mild hypogonadism in this generation (Fig. 4a ). For reference, Fig. 4c, d shows a stage VII tubule from an unaffected littermate, with layers of differentiating germ cells culminating in elongated spermatids with their tails extending into the lumen. In the caput epididymis from the same animal (Fig. 4e) , columnar epithelial cells line the lumen, which is tightly packed with sperm. A testis tubule from an affected F1 littermate also shows multiple layers of round germ cells (Fig. 4f) , similar to the unaffected animal. However, examination at higher magnification revealed the absence of elongated spermatids (Fig. 4g, arrow) , suggesting that spermiogenesis failed to occur normally. The epididymis from this animal appears normal but the lumen is devoid of mature sperm, though small numbers of round germ cells are observed (Fig. 4h,  arrow) . F1 mice were intercrossed to determine if a more severe phenotype was observed in the homozygous state. Twentytwo percent of F2 progeny were severely hypogonadal (n = 47 of 216), appropriate for a recessive trait, with a mean testis weight of 33 mg compared to 102 mg for (Fig. 4b) . Germ cells in the seminiferous tubules of hypogonadal animals were all premeiotic (Fig. 4i, j) and some nuclei were pyknotic, consistent with other severely hypogonadal ENU mutants. No germ cells were observed in the epididymis (Fig. 4k) .
DNA was collected from 73 animals with either spermatogenic block, predicted to be heterozygous, or severe hypogonadism, predicted to be homozygous. SNP analysis yielded a broad region on chromosome 17, and sequencing of candidate gene exons identified a nonsynonymous mutation (nucleotide A739T; amino acid L247Stop) in the gene for PR domain containing 9 (Prdm9). Prdm9 was initially reported as a histone methyltransferase involved in the progression of early meiotic prophase (Hayashi et al. 2005) , consistent with the histology observed here.
Discussion
ENU mutagenesis has evolved rapidly in the last 15 years. This acceleration reflects several parallel events: (1) investment by funding agencies in mutagenesis centers (Boles et al. 2009; Justice et al. 1999; Moldin et al. 2001) , building on early successes in the identification of diseasespecific genes; (2) development of genome-wide and tailored SNP arrays, which greatly simplify the mapping of loci in mutant mouse lines; and (3) advances in DNA sequencing, which provided the human and mouse reference genomes (Durbin et al. 2010; Lander et al. 2001; Venter et al. 2001; Waterston et al. 2002) , as well as the ability to quickly identify base changes responsible for observed phenotypes (Boles et al. 2009 ).
The current screen was designed to identify genes required for spermatogenesis and related urogenital functions. Mutations in these genes are potential causes of male infertility. One concern when planning this screen was whether mutations in genes that impair male germ cell development would have similar effects in the female germline, thus precluding propagation of the mutants through either sex. In this respect the ReproGenomics screen at the Jackson Laboratory was informative. When searching for genes required for fertility, this group found a preponderance of mutants that caused male-only infertility (Handel et al. 2006) , with far fewer genes causing infertility in both sexes. Our own experience is consistent with these results. Three dominant lines with germ cell loss (624, 1003, and 924), all derived from male G1 founders, could not be pursued due to poor breeding and transmission. Of the two dominant lines in which mutations were successfully identified, one (line 708; Plk4) had a mild phenotype (Harris et al. 2011 ) and the other (line 1157; SnrpE) was derived from a female G1. We included female G1 founders in the screen specifically to address this concern about fertility, based in part on the results from the previous screen. G1 males are more commonly used in ENU screens to allow trio or harem breeding, which expedites the generation of progeny for screening.
Several other adjustments were also made to enhance efficiency. The current screen was designed primarily to detect mutations with dominant inheritance, owing to the simplified breeding compared to a recessive screen. In an attempt to capture a subset of the recessive alleles, dominant crosses that yielded a mild phenotype or which exhibited low penetrance were selectively inbred to identify potential recessive traits. The incomplete dominance in line 1045 (Prdm9) was identified in this manner, as was the severe hypogonadism in line 1078. As noted, however, this strategy was not universally successful. Overall, we encountered five lines for which the transmission rate was too low in either cross to allow the lines to be studied beyond low-resolution mapping (Table 1) . Generating enough affected animals would have required very large colonies. In some of these lines transmission was low in the initial B6 crosses, possibly reflecting a multigenic etiology. In others we observed a loss of penetrance specifically when backcrossing to the DBA strain for mapping. In the latter case, affected mice were crossed to several additional strains without a rescue of the phenotype. These data are consistent with the known sensitivity of the B6 strain to disruption of the reproductive axis, an effect we have also observed with targeted knockouts (Raverot et al. 2005) .
Identified mutations were confirmed in additional progeny from the same line. Initially, sequencing was performed in related animals to allow direct comparison of littermates. Subsequently, larger groups of affected and unaffected mice were sequenced to confirm the correlation of genotype to phenotype. We identified a number of SNPs, either synonymous or in noncoding regions, that did not track with the phenotype. However, all of the mutations reported here were transmitted in tight association with the phenotype. Two of the mutations (Plk4, Rxfp2) were further demonstrated to be causative using genetic complementation assays (Harris et al. 2010 (Harris et al. , 2011 . The remaining genetic variants remain candidates until they are confirmed with additional complementation assays or by replication of the phenotype after introducing the mutation into wildtype mice using standard gene-targeting techniques.
To estimate the completeness of the screen we used several known metrics and calculated the genomic coverage using a computational simulation. The mice used in this study were produced as part of an established mutagenesis program at Northwestern University (Vitaterna et al. 1994) , in which the estimated forward mutation rate was 0.0015 per locus per gamete, or about 1 in 700. Using a figure of 20,210 protein-coding genes in the mouse genome (Church et al. 2009 ), it was estimated that each G1 mouse harbored 29 independent mutations, on average. Beginning with the 1,014 gametes (G1 mice) screened, simulating the mutagenesis process over 100 trials to account for random variability yielded an estimated coverage of 15,262 genes, or 77% of the mouse genome. By extension, to mutate each gene at least once with 95% confidence would have required the screening of 6,537 gametes. This simple approximation does not account for fold coverage, variability of the forward mutation rate across the genome, or several other factors. However, based on this estimate we would have expected a diminished screening efficiency beyond the initial thousand G1 mice examined under the specific conditions used in this study.
The genes ultimately identified in this screen were informative. Although several were previously known to be involved in spermatogenesis, notable insights were still achieved. The Prdm9 gene is a good example in this regard. Initially known as Meisetz, Prdm9 was shown to be a histone H3 methyltransferase necessary for meiotic prophase. Mice with targeted deletion of this gene were sterile in both sexes due to severe impairment of the doublestranded DNA break repair pathway, deficient pairing of homologous chromosomes, and impaired sex body formation (Hayashi et al. 2005) . However, heterozygous null animals were fertile. Prdm9 was subsequently shown to be a hybrid sterility gene that plays a role in mammalian speciation (Mihola et al. 2009 ) by controlling meiotic recombination hotspots (Baudat et al. 2010; Parvanov et al. 2010) , the first such gene identified in a vertebrate species. In the present study, it was observed that haploinsufficiency of Prdm9 results in a late spermatogenic block, precluding spermiogenesis. Notably, this defect was manifest subsequent to meiosis and was therefore not observed in the previous reports. Thus, the ENU allele unmasked a second requirement for Prdm9 in spermatogenesis and extends the known roles of this gene.
The cryptorchid mutant (line 1061), which has a mutation in Rfxp2, also extends our understanding of the function of this gene. The human homolog, RXFP2, is a cell surface receptor that is well known to cause cryptorchidism when mutated in patients (Ferlin et al. 2003) . For this reason, its biochemical mechanism has been studied in detail. Fortuitously, aspartic acid 275 in human RXFP2, which is structurally equivalent to the D294 residue mutated in the current ENU mouse mutant, has been examined in vitro. Mutation of human D275 did not affect cell surface expression but precluded binding of its ligand, INSL3. In contrast, mutation of mouse D294 decreased trafficking of the receptor to the cell surface but there was normal signaling by the relatively small amounts of receptor that did localize to the membrane (Harris et al. 2010) . The presence or absence of the receptor on the cell surface is important relative to any attempt to manipulate RXFP2 using agonists or antagonists in cryptorchid patients. Thus, ENU mutants can be informative even when the relevant gene has been well studied, and in this case highlights an evolutionary divergence.
The final two lines identified in this study highlight the promise (line 1157) and also the remaining challenges (line 1078) in mutagenesis screening. In both cases, the SNP arrays were followed by manual mapping with additional SNPs, thus narrowing the regions carrying the mutation to 1.34 and 1.44 Mb, respectively. In line 1157, the exons and intron-exon boundaries were sequenced for 13 genes considered candidates based on known physiological or biochemical activity. In line 1078, all of the exons and intron-exon boundaries in the region were sequenced as part of a pilot program at the Broad Institute. In both cases the background strains (B6 and DBA) were also sequenced using DNA from the same colonies as the affected animals. This method allowed direct comparisons to identify sequence differences, rather than relying on genomic databases. In neither case did exon sequencing reveal the causative mutation, indicating that the mutations were either in a regulatory sequence, an intron, or in a gene lacking any known activity relevant to germ cells or the testis.
Using recently available methods, both intervals were resequenced after genomic enrichment and an aspartic acid-to-glutamic acid substitution was identified in the SnrpE gene in line 1157. Although the E51D substitution is biochemically conservative, we note that the SnrpE amino acid sequence is 100% conserved between humans, mice, and chickens (Fautsch et al. 1992) . These data suggest that amino acid substitutions, however conservative, are strongly selected against. SnrpE belongs to a group of proteins that associate with the U family of small nuclear RNAs, which are involved in RNA processing (Stanford et al. 1988) . Despite its participation in this fundamental cellular activity, there is no reported example of a specific physiological function that is dependent on SnrpE. Thus, in this case mutagenesis screening has likely identified an entirely novel cause of male infertility.
In line 1078 we were unable to identify a candidate for the causative mutation. It is unlikely that this mutation resides in a coding sequence because the relevant exome was sequenced twice independently, once at the Broad Institute and once during genomic resequencing. A more plausible explanation is that the mutation resides in an intervening sequence that was not well covered in our resequencing. Approximately 91.5% of the interval containing the mutation in line 1078 was sequenced at a coverage of tenfold or higher, a useful target for separation of valid polymorphisms from technical artifacts in the sequencing reads. Approximately 3.9% of the interval failed to sequence at all. Notably, in an exhaustive resequencing study involving 41 ENU mutants, Boles et al. (2009) found that 61% of their identified mutations were located outside of the coding regions. While only a fraction of those sequence changes may ultimately be proven causative, this study further highlights the importance of mutations in structural and regulatory regions. It is also possible that this line harbors a natural mutation of a different class (e.g., a mobile element insertion), and care must be taken in the analysis not to overlook mutations that are different from the expected single base changes.
In summary, we found that ENU mutagenesis is an effective tool for identifying candidate genes for male infertility and milder reproductive phenotypes. While some of these genes are novel, this pool will likely diminish as the human and mouse genomes become more completely annotated. However, insights may still be gained from assigning new roles to genes previously associated with nonreproductive functions, as described above for Prdm9 and Rxfp2.
